PTH and vitamin D deficiency: PHP type I (PHP1A and PHP1B) patients are characterized by end-organ resistance to the action of the parathyroid hormone (PTH), which leads to hypocalcemia, hyperphosphatemia, and elevated levels of PTH in the absence of vitamin D deficiency.